Xiamen Yan Palace Bioengineering Pre-IPO Tearsheet
Xiamen Yan Palace Bioengineering (1951686D CH) is looking to raise around US$200m in its upcoming Hong Kong IPO. The deal will be run by CICC and...
501 Views
𝛼SK or SearchENTITY
Xiamen Yan Palace Bioengineering (XIAMEN HK)
Xiamen Yan Palace Bioengineering (XIAMEN HK)
7
Analysis
Health Care • China
Xiamen Yan Palace Bioengineering Co. Ltd. manufactures and distributes food supplements. The Company produces freshly stewed bird's nest, dry bird's nest, and other products. Xiamen Yan Palace Bioengineering conducts businesses in China.
morex